Palatin Technologies, Inc. 0KF3.L Stock
Palatin Technologies, Inc. Price Chart
Palatin Technologies, Inc. 0KF3.L Financial and Trading Overview
| Palatin Technologies, Inc. stock price | 1.97 USD |
| Previous Close | 3 USD |
| Open | 0 USD |
| Bid | 0 USD x N/A |
| Ask | 0 USD x N/A |
| Day's Range | 0 - 0 USD |
| 52 Week Range | 0 - 4.8 USD |
| Volume | 405 USD |
| Avg. Volume | 1.63K USD |
| Market Cap | 708.69M USD |
| Beta (5Y Monthly) | 0.906 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.157 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
0KF3.L Valuation Measures
| Enterprise Value | 33.74M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 116.36984 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 5.54 |
| Enterprise Value/EBITDA | -1.105 |
Trading Information
Palatin Technologies, Inc. Stock Price History
| Beta (5Y Monthly) | 0.906 |
| 52-Week Change | N/A |
| S&P500 52-Week Change | N/A |
| 52 Week High | 4.8 USD |
| 52 Week Low | 0 USD |
| 50-Day Moving Average | 2.16 USD |
| 200-Day Moving Average | 2.42 USD |
0KF3.L Share Statistics
| Avg. Volume (3 month) | 1.63K USD |
| Avg. Daily Volume (10-Days) | 2.28K USD |
| Shares Outstanding | 203.06M |
| Float | 13.17M |
| Short Ratio | N/A |
| % Held by Insiders | 3.97% |
| % Held by Institutions | 15.06% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2023 |
| Most Recent Quarter (mrq) | September 30, 2023 |
| Next Fiscal Year End | June 30, 2024 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -290.074% |
| Gross Margin | -260.42% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -99.13% |
| Return on Equity (ttm) | -1414.19% |
Income Statement
| Revenue (ttm) | 6.09M USD |
| Revenue Per Share (ttm) | 0.53 USD |
| Quarterly Revenue Growth (yoy) | 142.19% |
| Gross Profit (ttm) | -18195369 USD |
| EBITDA | -30526368 USD |
| Net Income Avi to Common (ttm) | -25174878 USD |
| Diluted EPS (ttm) | -0.157 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 5.52M USD |
| Total Cash Per Share (mrq) | 0.4 USD |
| Total Debt (mrq) | 934.33K USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.72 |
| Book Value Per Share (mrq) | -0.409 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -25744074 USD |
| Levered Free Cash Flow (ttm) | -19437220 USD |
Profile of Palatin Technologies, Inc.
| Country | United Kingdom |
| State | NJ |
| City | Cranbury |
| Address | Cedar Brook Corporate Center |
| ZIP | 08512 |
| Phone | 609 495 2200 |
| Website | https://palatin.com |
| Industry | |
| Sector(s) | |
| Full Time Employees | 34 |
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing oral PL8177, a selective MC1r agonist peptide that is in Phase 2 clinical trial for the treatment of inflammatory bowel diseases. In addition, the company engages in the development of PL9643, a peptide melanocortin agonist active at multiple MCrs, including MC1r and MC5r for anti-inflammatory ocular indications, such as dry eye disease, which is in Phase 3 clinical trial; and melanocortin peptides for diabetic retinopathy. Further, it is developing PL8177, an oral peptide formulation for treatment of ulcerative colitis, which entered Phase 2 clinical trials. The company was founded in 1986 and is based in Cranbury, New Jersey.
Q&A For Palatin Technologies, Inc. Stock
What is a current 0KF3.L stock price?
Palatin Technologies, Inc. 0KF3.L stock price today per share is 1.97 USD.
How to purchase Palatin Technologies, Inc. stock?
You can buy 0KF3.L shares on the LSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Palatin Technologies, Inc.?
The stock symbol or ticker of Palatin Technologies, Inc. is 0KF3.L.
How many shares does Palatin Technologies, Inc. have in circulation?
The max supply of Palatin Technologies, Inc. shares is 2.75M.
What is Palatin Technologies, Inc. Price to Earnings Ratio (PE Ratio)?
Palatin Technologies, Inc. PE Ratio is now.
What was Palatin Technologies, Inc. earnings per share over the trailing 12 months (TTM)?
Palatin Technologies, Inc. EPS is -0.157 USD over the trailing 12 months.